Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Prestige Consumer Healthcare (PBH) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Prestige Consumer Healthcare (PBH) over the last 17 years, with Q4 2025 value amounting to 29.1%.

  • Prestige Consumer Healthcare's EBIT Margin fell 25700.0% to 29.1% in Q4 2025 from the same period last year, while for Dec 2025 it was 29.21%, marking a year-over-year decrease of 3500.0%. This contributed to the annual value of 29.6% for FY2025, which is 8300.0% down from last year.
  • Prestige Consumer Healthcare's EBIT Margin amounted to 29.1% in Q4 2025, which was down 25700.0% from 29.06% recorded in Q3 2025.
  • In the past 5 years, Prestige Consumer Healthcare's EBIT Margin registered a high of 33.93% during Q2 2021, and its lowest value of 98.3% during Q1 2023.
  • For the 5-year period, Prestige Consumer Healthcare's EBIT Margin averaged around 23.6%, with its median value being 29.77% (2024).
  • Per our database at Business Quant, Prestige Consumer Healthcare's EBIT Margin crashed by -1273000bps in 2023 and then soared by 1279500bps in 2024.
  • Prestige Consumer Healthcare's EBIT Margin (Quarter) stood at 30.09% in 2021, then grew by 5bps to 31.64% in 2022, then decreased by -3bps to 30.71% in 2023, then increased by 3bps to 31.68% in 2024, then fell by -8bps to 29.1% in 2025.
  • Its EBIT Margin was 29.1% in Q4 2025, compared to 29.06% in Q3 2025 and 28.76% in Q2 2025.